As the AR+ and AR-KO clonal cells are implanted in the same castrated host, the results (Fig. 4) also provide the first hint that AR-KO cells possess a competitive advantage over AR+ tumor cells in regenerating tumors in the absence of androgen. The gene discussed is AR; the disease is neoplasm.